Clinical Trials for Compass Pathways

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Compass Pathways

Clinical Trials (5)

NCT06247839
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
PHASE3Recruiting
20 participants
Started: Sep 10, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05711940
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
PHASE3Recruiting
568 participants
Started: Feb 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor118 locations
NCT05733546
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
PHASE2Active, not recruiting
102 participants
Started: Jan 30, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor5 locations
NCT05624268
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD
PHASE3Active, not recruiting
255 participants
Started: Jan 19, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor40 locations
NCT04433858
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
PHASE2Active, not recruiting
27 participants
Started: Mar 1, 2021 · Completed: May 1, 2026
1 condition2 sponsors2 locations